Showing results (41-50 of 6,995) with videos related to

Sort By:
Pageof 700
Lung Cancer (Amsterdam, Netherlands)|January 7, 2015
Choroidal metastasis response to crizotinib in a ROS1-rearranged NSCLC patientStephanie Lu, Michele C Azada, Sai-Hong Ignatius Ou
Lung Cancer (Amsterdam, Netherlands)|July 6, 2014
Blood vessel invasion is a major feature and a factor of poor prognosis in sarcomatoid carcinoma of the lungThibault Vieira, Martine Antoine, Anne-Marie Ruppert, et al.
Lung Cancer (Amsterdam, Netherlands)|July 6, 2014
Randomized phase II study of carboplatin and etoposide with or without obatoclax mesylate in extensive-stage small cell lung cancerCorey J Langer, Istvan Albert, Helen J Ross, et al.
Lung Cancer (Amsterdam, Netherlands)|September 2, 2014
Identification of actionable mutations in malignant pleural mesotheliomaTakehito Shukuya, Masakuni Serizawa, Masaru Watanabe, et al.
Lung Cancer (Amsterdam, Netherlands)|June 13, 2013
Clinical significance of survivin and VEGF mRNA detection in the cell fraction of the peripheral blood in non-small cell lung cancer patients before and after surgeryX-P Tang, J Li, L-C Yu, et al.
Lung Cancer (Amsterdam, Netherlands)|June 8, 2012
Prognostic factors for non-small cell lung cancer with bone metastasis at the time of diagnosisHyun-Mi Bae, Se-Hoon Lee, Tae Min Kim, et al.
Lung Cancer (Amsterdam, Netherlands)|May 29, 2012
Survival among non-small cell lung cancer patients with poor performance status after first line chemotherapyRamzi G Salloum, Thomas J Smith, Gail A Jensen, et al.
Lung Cancer (Amsterdam, Netherlands)|March 26, 2013
Pemetrexed-induced neutropenic enteritis and severe cutaneous hyperpigmentation in a patient with malignant pleural mesotheliomaKatharina Buchinger, Rolf Stahel, Verena Niggemeier, et al.
Lung Cancer (Amsterdam, Netherlands)|March 26, 2013
Thymidylate synthase and ERCC1 as predictive markers in patients with pulmonary adenocarcinoma treated with pemetrexed and cisplatinSeung Hyeun Lee, Kyung Bo Noh, Ji Sung Lee, et al.
Lung Cancer (Amsterdam, Netherlands)|March 23, 2013
Screening for brain metastases in patients with stage III non-small cell lung cancer: Is there additive value of magnetic resonance imaging above a contrast-enhanced computed tomography of the brain?Lizza E L Hendriks, Gerben P Bootsma, Dirk K M de Ruysscher, et al.
Pageof 700